Efficiency hub

The National Comprehensive Cancer Network developed a toolkit to standardise chemotherapy procedures and shift services from inpatient to outpatient settings.

The National Childhood Cancer Care Network in Paraguay introduced regional satellite clinics to improve access to diagnosis and treatment for children with cancer.

oPuce, a social enterprise and foundation in the Netherlands, aims to improve employment opportunities and job retention for cancer survivors and people living with cancer.

In Norway, people with cancer often have to travel considerable distances to access palliative care at larger hospitals. The Orkdal Hospital introduced an integrated clinic to combine cancer and palliative care for people in the rural Orkdal region.`

AV1 is a telepresence robot that enables children and young people with long-term illness, including cancer, to attend school remotely.

Survivors of cancer may face a complex combination of physical, psychological and social issues following the completion of active treatment. A multidisciplinary cancer rehabilitation centre in Stockholm, Sweden offers a person-centred solution.

In Europe, survival rates for several types of cancer vary considerably between countries. This may be due to differences in lifestyle factors and care-seeking behaviours, but it may also result from unwanted variation in the provision and quality of cancer care. In 2002, the Organisation of European Cancer Institutes (OECI) launched the Accreditation and Designation (A&D) Programme to improve and standardise care and research in European cancer centres.

Prostate cancer is the most common type of cancer among men in the United Kingdom (UK). The Christie NHS Foundation Trust introduced community-based prostate cancer clinics led by specialist nurses in order to overcome challenges experienced by prostate cancer patients with regards to follow-up appointments after radiotherapy and/or surgery.

The UK has lower survival rates for many types of cancer than the rest of Europe, partly due to delays in diagnosis. When people present with non-specific symptoms, general practitioners may find it difficult to determine whether further clinical investigations are needed. This may delay access to treatment, limit treatment options and reduce survival rates. To address this, Macmillan Cancer Support developed a Cancer Decision Support tool that calculates a person’s risk of having an undiagnosed cancer based on symptoms, medical history and demographic data, and helps GPs consider whether further testing or specialist referral is needed.